Using theory of planned behaviour, this study seeks to examine the effect of health practitioner’s interaction with pharmaceutical sales representatives on their prescription behaviour. Data was collected from 248 health practitioners working in the city of Attock and from five Tehsils of Attock District through questionnaires with a net response rate of 82%. The hypothesis was tested by PLS Path Modelling. The major findings of the study were that physicians’ interactions with pharmaceutical sales representatives in terms of market knowledge, product knowledge, corporate reputation and tangible rewards affect the prescription behaviour of physicians directly as well as through the mediating effect of the attitudinal component. The findings of the study would be helpful for the pharmaceutical industry as well as for drug regulatory authorities and health policy makers towards unethical practices in the medical field. Study provided practical implications for policy makers and health practitioners. Moreover, future directions for research were also provided.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Ahearne, M., & Schillewaert, N. (2000). The effect of information technology on salesperson performance. State College, PA: Pennsylvania State University.
Ajzen, I. (1991). The theory of planned behaviour. Organizational Behavior and Human Decision Process,50, 179–211.
Ajzen, I. (2001). Nature and operation of attitudes. Annual Review of Psychology,52(1), 27–58.
Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behavior. Englewood Cliffs: Prentice-Hall.
Al-Areefi, M. A., & Hassali, M. A. (2013). The role of pharmaceutical marketing and other factors in prescribing decisions: The Yemeni experience. Research in Social and Administrative Pharmacy,9(6), 981–988.
Anderson, J. C., & Gerbing, G. W. (1988). Structural equation modelling in practice: A review and recommended two-step approach. Psychological Bulletin,103(3), 411–423.
Avorn, J., Chen, M., & Hartley, R. (1982). Scientific versus commercial sources of influence on the prescribing behavior of physicians. The American Journal of Medicine,73(1), 4–8.
Cai, Y., & Shannon, R. (2012). Personal values and mall shopping behaviour: The mediating role of intention among Chinese consumers. International Journal of Retail & Distribution Management,40(4), 290–318.
Campo, K., DeStaebel, O., Gijsbrechts, E., & Van-Waterschoot, W. (2005). Physicians’ decision process for drug prescription and the impact of pharmaceutical marketing mix instruments. Health Marketing Quarterly,22(4), 73–107.
Chen, C., Dong, W., Shen, J. J., Cochran, C., Wang, Y., & Hao, M. (2014). Is the prescribing behavior of Chinese physicians driven by financial incentives? Social Science & Medicine,120, 40–48.
Cialdini, R. B., Petty, R. E., & Cacioppo, J. T. (1981). Attitude and attitude change. Annual Review of Psychology,32, 357–404.
Crosby, L. A., & Muehling, D. D. (1983). External variables and the fishbeinmodel: Mediation, moderation, or direct effects. NA - Advances in Consumer Research,10(35), 94–99.
De Ferrari, A., Gentille, C., Davalos, L., Huayanay, L., & Malaga, G. (2014). Attitudes and relationship between physicians and the pharmaceutical industry in a Public General Hospital in Lima, Peru. PLoS ONE,9(6), e100114.
Fombrun, C. J., & Gardberg, N. (2000). Who’s tops in corporate reputation? Corporate Reputation Review,3(1), 13–17.
Fombrun, C., & Van Riel, C. (1997). The reputational landscape. Corporate Reputation Review,1(2), 5–13.
Fornell, C., & Cha, J. (1993). Partial least squares (PLS), Unpublished working paper. Ann Arbor: University of Michigan Business School.
Fornell, C., & Larcker, D. F. (1981). Structural equation models with unobservable variables and measurement error: algebra and statistics. Journal of Marketing Research,18(3), 382–388.
Hair, F. J., Jr., Sarstedt, M., Hopkins, L., & Kuppelwieser, V. G. (2014). Partial least squares structural equation modeling (PLS-SEM): an emerging tool in business research. European Business Review,26(2), 106–121.
Handa, M., Vohra, A., & Srivastava, V. (2012). Ethics: The physician–pharma dyad in India. Asian Journal of Business Ethics,3(1), 1–10.
Jones, E., Chonko, L. B., & Roberts, J. A. (2003). Creating a partnership-oriented knowledge and creation culture in strategic sales alliances: A conceptual framework. Journal of Business & Industrial Marketing,18(4), 336–353.
Madhavan, S., Amonkar, M. M., Elliott, D., Burke, K., & Gore, P. (1997). The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. Journal of Clinical Pharmacy and Therapeutics,22(3), 207–218.
Manchanda, P., & Honka, E. (2005). The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review. Yale Journal of Health Policy, Law, and Ethics,5(2), 8.
McGettigan, P., Golden, J., Fryer, J., Chan, R., & Feely, J. (2001). Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. British Journal of Clinical Pharmacology,51(2), 184–189.
McKinney, W. P., Schiedermayer, D. L., Lurie, N., Simpson, D. E., Goodman, J. L., & Rich, E. C. (1990). Attitudes of internal medicine faculty and residents towards professional interactions with pharmaceutical sales representatives. JAMA,264, 1693–1697.
Moynihan, R. (2003). Who pays for the pizza? Redefining the relationships between physicianss and drug companies. British Medical Journal,326(7400), 1189–1192.
Norris, P., Herxheimer, A., Lexchin, J., & Mansfield, P. (2005). Drug promotions; what we know, what we have yet to learn: reviews of materials in the WHO/HAI database on drug promotion. Amsterdam: WHO/HAI.
Preacher, K. J., & Hayes, A. F. (2004). SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, Instruments, & Computers,36(4), 717–731.
Preacher, K. J., & Hayes, A. F. (2008). Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods,40(3), 879–891.
Ringle, C., Da Silva, D., & Bido, D. (2015). Structural equation modeling with the smartpls. Brazilian Journal of Marketing,13(2), 56–73.
Theodorou, M., Tsiantou, V., Pavlakis, A., Maniadakis, N., Fragoulakis, V., Pavi, E., et al. (2009). Factors influencing prescribing behaviour of physicians in Greece and Cyprus: Results from a questionnaire based survey. BMC Health Services Research,9(1), 150.
Waheed, K., Jaleel, M., & Laeequddin, M. (2011). Prescription loyalty behavior of physicians: An empirical study in India. International Journal of Pharmaceutical and Healthcare Marketing,5(4), 279–298.
Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift?. Palo Alto: Stanford University Medical Center.
Wulf, K. D., & Odekerken-Schroder, G. (2003). Assessing the impact of a retailer’s relationship efforts on consumersattitudes and behavior. Journal of Retailing and Consumer Services,10(2), 95–108.
Zaki, N. M. (2014). Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study. Saudi Pharmaceutical Journal,22(6), 528–536.
Zipkin, D. A., & Steinman, M. A. (2005). Interactions between pharmaceutical representatives and doctors in training: a thematic review. Journal of General Internal Medicine,20(8), 777–786.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Faisal, A., Ahmad, M.S., Thurasamy, R. et al. Doctors’ Interactions with Pharmaceutical Sales Representatives: Modelling Doctors Prescription Behaviour. Community Ment Health J 56, 456–463 (2020). https://doi.org/10.1007/s10597-019-00501-w
- Prescription behaviour
- Pharmaceutical marketing
- Pharmaceutical sales representatives (PSRs)